EXAMPLES OF FUNDED PROJECTS
Project Acronym: SMCéco. Theme: composite materials & development processes. Objective: To develop a processing technology SMC (sheet molding compound) compatible with the economic criteria for producing small and medium series (a few hundred to a few thousand pieces) for the sake of economic and environmental technical performance. This method thus provide an alternative to contact molding and / or injection RTM with a reduced rate of labor work, working conditions improved (reduction of VOC emissions) and quality levels and increased technology. Key target applications: bus parts, pieces from the railway sector, electrical parts (housings, enclosures and busbar supports current) large parts to the building such as claddings. Partners: CCP Composites Compin, Compose, Compositec, Mader, Nief Plastic, University of Haute Alsace, united University of Strasbourg.
Project Acronym: Nucleo. Theme: biomaterials. Objective: To improve the oral health of the population by reducing the risk of post operative infection following the placement of dental implants. An implant therapy access could then be offered to patients at risk (diabetic, transplant, HIV carriers …) can not to this day benefi such treatment. Indeed, as many studies show, after the installation of dental implant complications infl ammatory infectious origin, such as mucositis and peri-implantitis can affect peri-implant tissues. These complications affect up to 60% of individuals and 40% of implants placed. The development of an implant antibacterial treatment appears to be a promising solution to mitigate these risks and represents an interesting challenge for the field of public health. To achieve this goal, we propose to synthesize an implant coating of bioactive natural polymer with antiseptic properties and / or healing that will after implant placement in mouth, slow and controlled return of the active ingredient for action curative. The synthesis of bioactive implant coating is followed by chemical characterization, mechanical and biological advanced technology to validate the proposed solution. A study of prototyping is then conducted to demonstrate its feasibility on an industrial scale. Another important part of the project concerns the study of the sterilization of the new implant devices without risk of denaturation of the active ingredient. Fi nally, the validation of the whole process, in terms of placing on the new device and regulatory market will close the project. The consortium gathered around this ambitious project is a real synergy between partners resulting in a complementary multidisciplinary skills of the latter. Market: Medical. Partners: Tekka, Rescoll, Science and surface Nosocotech and UCBL Laboratory-IMP